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SUMMARY
Positive troponin test results in peripheral blood can be detected either during myocardial injury 
or from falsely positive test results. In this report, we present the positive results of a troponin 
test in a 24-year-old pregnant woman referred to the emergency department with atypical chest 
pain, and the clinical algorithm that we used to make the correct diagnosis. This patient present-
ed with the same complaint of chest pain at different times while positive troponin levels were 
detected. In the absence of signs of myocardial injury, we suspected that heterophil antibodies 
were playing a major role. Further examinations revealed heterophil antibodies that could cross 
react with the troponin tests in peripheral blood.
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Introduction
As a result of myocardial infarction, enzymes such as myo-
globin, cardiac troponins, creatine kinase, and lactate dehy-
drogenase rise in the blood. Among these, cardiac troponins 
play a special role by virtue of their characteristics of being 
released only from cardiac muscle; increased levels even in 
minor myocardial injury retain the ability to make a diagno-
sis with high sensitivity and accuracy. As a result, European 
and American societies of cardiology have recommended 
the use of troponin I or T as a diagnostic laboratory criterion 
of myocardial infarction since 2000.[1] Elevated level of tro-
ponin indicates myocardial injury in spite of no information 
about the cause of the injury.
Apart from myocardial infarction, positive troponin level 
may also be detected due to myocardial injury or false posi-
tive test results.[2,3] In this report, we aimed to present a case 
with troponin positivity due to heterophil antibodies.
Case Report
A 24-year-old housewife referred to the emergency depart-
ment with left submammarian chest pain that was con-
fined to a point and increased with leaning forward or deep 
breathing (November 14th). Due to a positive troponin level 
she was transferred to the cardiology polyclinic (troponin-
I level: 0.20 ng/mL, reference level: 0-0.04 ng/ml) (Table 1). 
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Her medical history was remarkable for being 20 weeks 
pregnant. She had no history of heart disease, medication 
use, cigarette smoking, alcohol, or drug abuse. Function-
ally, she was in a good status. Her physical examination was 
unremarkable. Both electrocardiography and echocardiog-
raphy were negative with respect to perimyocarditis, myo-
cardial ischemia, or myocardial infarction. Other blood tests 
were normal for creatine kinase (CK), creatine kinase MB 
isoenzyme (CK-MB), and alkaline phosphatase or rheuma-
toid factor (Table 2) with false positive potential in result of 
troponin level. As she revealed she had similar complaints 
before pregnancy with positive troponin levels (Table 1). 
In the absence of typical myocardial ischemia, which was 
not confirmed by electrocardiography, echocardiography 
or normal range result of the CK and the CK-MB despite 
troponin-I elevatıon, we concluded the possibility of labora-
tory error that resulted in a false positive troponin elevation. 
For increased accuracy of the test result we surveyed the 
result in two different laboratories simultaneously (Novem-
ber 15th). The obtained laboratory results showed positive 
troponin-I levels in our center with normal troponin-T levels 
in another center. When the same sample was studied using 
the interference test at our laboratory, the troponin-I level 
was found within the normal range. The false positivity was 
attributed to interference of heterophil antibodies and her 
blood sample was sent to a tertiary center to search for het-
erophil antibodies.
Discussion
Cardiac troponins are sensitive and specific laboratory mark-
ers for myocardial injury and thus replaced CK-MB, the con-
ventional diagnostic marker. Troponins are currently consid-
ered the gold standard for the diagnosis of acute myocardial 
infarction.[1,4] Depending on the cellular damage, cardiac tro-
ponins begin to emerge in plasma 4-6 hours after the onset 
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Table 1. Patient’s troponin levels during eight months 
Date-Hour Troponin-I CK CK-MB Troponin-T Studying
 (reference) (reference) (reference) (reference) laboratory
April 4th 0.20 (0-0.04 ng/ml)    Our laboratory
01:59 p.m.(*)
April 4th 0.21 (0-0.04 ng/ml)    Our laboratory
04:42 p.m.
April 4th    <0.01µg/L (<0.01µg/L) 1st outside center
10:12 p.m.   
November 14th 0.20 (0-0.04 ng/ml)  11 (0-25 u/l)  Our laboratory
08:11 p.m.(#)
November 15th 0.20 (0-0.04 ng/ml)    Our laboratory
00:56 a.m.(#)
November 15th 0.24 (0-0.04 ng/ml) 46 (0-145 u/l) 10 (0-25 u/l)  Our laboratory
09:56 a.m.
November 15th    <0.01µg/L (<0.01µg/L) 2nd outside center
12:23 p.m.
November 20th 0.20 (0-0.04 ng/ml) 53 (0-145 u/l) 11 (0-25 u/l)  Our laboratory
03:28 p.m.(#)
(*): Blood results before pregnancy. (#): Blood results during pregnancy.
Table 2. Other blood results from the patient
Date WBC RBC HGB HTC PLT CRP ALP AST RF
 (reference)  (reference)  (reference)  (reference)  (reference)  (reference)  (reference)  (reference)  (reference)
November 7.4 x109 L 4.05 x1012 L 12.1 g/dL 35.9% 230 x109 L 4 mg/dl 52.39 U/L 19 u/I 4 IU/L
20th (4-12x109 L) (3. 5-5.2 x1012 L) (12-16 g/dL) (35-49%) (130-450x109 L)  (0-5 mg/dl)  (30-120 U/L)  (0-31 u/I) (0-18 IU/L)
WBC: White Blood Count; RBC: Red Blood Cells; HGB: Hemoglobin; HTC: Hematocrit; PLT: Platelet; CRP: C-reactive protein; ALP: Alkaline  Phosphatase; AST: Aspartate Trans-
aminase; RF: Rheumatoid Factor.
of ischemic symptoms and continue to be elevated for 10 
days to 2 weeks.[5]
Despite the advantages of troponins, clinicians should keep 
in mind other processes that elevate troponin levels apart 
from myocardial infarction.[2,3,6-11] While some of the events 
with troponin elevation other than myocardial infarction are 
associated with myocardial injury, some of them occur as a 
result of troponin tests giving false positive results.
Troponin positivity as a result of myocardial injury may occur 
with the following: congestive heart failure, coronary vaso-
spasm, cardiac trauma, myocarditis/perimyocarditis, pulmo-
nary embolism, post-cardiac surgery and cardiac ablation, 
cardioversion and cardiopulmonary resuscitation, sepsis, 
critically ill patients, end-stage renal disease, arrhythmias, 
stroke, and epileptic seizures.
False positive troponin testing may result from: heterophile 
antibodies, Rheumatoid factor, or macroenzymes. Several 
additional examples of interfering substances are found in 
the literature;[3,10,11] among which are circulating antibodies 
from immunotherapies, vaccinations or blood transfusions, 
fibrin clots, immunocomplexes, and malfunction of the ana-
lyzers.
We did not determine any clinical event that might have 
been associated with elevated troponin levels. Thus, we fo-
cused on the conditions with potential false positive tropo-
nin results. We ordered another test the same day at an out-
side center. The troponin-T result of the outside center was 
normal. Hence, we took a sample from the troponin positive 
blood sample and sent it to a tertiary center for testing for 
heterophil antibodies. The latter testing was positive for het-
erophil antibodies.
It has been reported that heterophil antibodies lead to a 
false positive result in one of 2000 patients assessed by 
modern immunoassay methods.[12] This condition may lead 
to misdiagnoses and unnecessary invasive interventions. 
Therefore, the clinicians should be vigilant about this in-
terference. In the event of any doubt, the suspicious blood 
sample should be studied with other devices using at least 
2 different methods.[12] Alternatively, this sample may be re-
evaluated by adding heterophil blocking reagents.[13]
Heterophil antibodies are formed in human serum against 
animal immunoglobulins. However, they usually do not lead 
to any clinical disease state, although they may interact with 
immunoassays.[14] The effects of heterophil antibodies on 
the immunoassays have been well documented.[15-17] Het-
erophil antibodies may arise accidentally or due to occupa-
tional exposure to foreign proteins. The chance of hetero-
phil antibody formation increases in people with frequent 
contact with animals such as veterinarians, farmers, or pet 
owners. They may also be formed as a result of administra-
tion of animal antibodies in cancer therapy or radiological 
tumor imaging.
Our patient was a woman living in a rural area where close 
contact with animals is prevalent. That may have led to de-
velopment of the heterophil antibodies in this patient.
Conclusion
As in our case, patients with an elevated troponin level but 
without clinical, electrocardiographic, or echocardiographic 
findings consistent with myocardial infarction or other con-
ditions that may have elevated troponin levels should be 
evaluated for the presence of heterophil antibodies before 
further invasive therapies are commenced. If heterophil an-
tibody positivity is suspected, troponin levels should be re-
evaluated with another device or method.
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